Q32 Bio (QTTB) Return on Capital Employed (2018 - 2026)

Q32 Bio's Return on Capital Employed history runs 9 years deep, the most recent figure standing at 41.13% for Q1 2026.

• On a quarterly basis, Return on Capital Employed rose 13039.0% year-over-year to 41.13% in Q1 2026; TTM through Mar 2026 was 41.13%, a 13039.0% increase from a year earlier, with the FY2025 full-year figure at 25.72%, up 14991.0% from the prior year.
• Return on Capital Employed rose to 41.13% in Q1 2026 per QTTB's latest filing, from 34.9% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 41.13% in Q1 2026 and bottomed at 89.65% in Q2 2025.
• The 5-year median for Return on Capital Employed is 55.07% (2022), against an average of 53.45%.
• Across the five-year window, Return on Capital Employed tumbled 3483 bps in 2025 and surged 13039 bps in 2026, its largest moves.
• Year by year, Return on Capital Employed stood at 59.77% in 2022, then retreated by 2 bps to 60.74% in 2023, then slumped by 33 bps to 80.64% in 2024, then jumped by 143 bps to 34.9% in 2025, then grew by 18 bps to 41.13% in 2026.
• Per Business Quant, the three latest QTTB Return on Capital Employed figures stand at 41.13% (Q1 2026), 34.9% (Q4 2025), and 85.57% (Q3 2025).